(AMST) Amesite Operating - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0310941051
AMST: Online Education Platform, Healthcare App, AI-powered Solutions
Amesite Operating Co (NASDAQ:AMST) is a technology firm specializing in AI-driven solutions for both consumer and enterprise markets. The companys product suite includes Amesite Engage, a platform designed for educational institutions to deliver professional skill-building courses and programs, leveraging AI to personalize learning experiences and enhance student outcomes. Additionally, Amesite offers NurseMagic, an AI-powered healthcare application tailored for nurses and caregivers, providing tools to manage job-related stress, streamline documentation, and improve task efficiency. The platform serves a diverse clientele, including enterprises, universities, and K-12 schools. Founded in 2017 and headquartered in Detroit, Michigan, Amesite focuses on integrating advanced AI technologies to address specific industry challenges. Web URL: https://www.amesite.com
Based on the provided data, the 3-month forecast for Amesite Inc. (NASDAQ:AMST) suggests a potential downtrend. The stock is currently trading below its 20-day, 50-day, and 200-day moving averages, with a last price of $2.27. The average volume of 74,319 shares over the past 20 days indicates moderate liquidity. The ATR of 0.33 reflects relatively low volatility. From a fundamental perspective, the companys market cap of $6.58M and P/S ratio of 112.24 suggest high valuation relative to sales, while the absence of P/E and forward P/E indicates a focus on growth over profitability. The P/B ratio of 7.88 signals a premium on book value, potentially reflecting investor confidence in future prospects. Over the next three months, the stock may face headwinds due to its current price trend and high valuations, though its focus on AI-driven solutions in education and healthcare could provide upside potential.
Additional Sources for AMST Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AMST Stock Overview
Market Cap in USD | 7m |
Sector | Technology |
Industry | Software - Application |
GiC Sub-Industry | Application Software |
IPO / Inception | 2020-09-25 |
AMST Stock Ratings
Growth 5y | -69.1% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | 0.8 |
Analysts | 5/5 |
Fair Price Momentum | 1.51 USD |
Fair Price DCF | - |
AMST Dividends
No Dividends PaidAMST Growth Ratios
Growth Correlation 3m | -84.3% |
Growth Correlation 12m | 17.7% |
Growth Correlation 5y | -86.6% |
CAGR 5y | -51.11% |
CAGR/Max DD 5y | -0.52 |
Sharpe Ratio 12m | -0.98 |
Alpha | -1.72 |
Beta | 1.27 |
Volatility | 109.62% |
Current Volume | 42k |
Average Volume 20d | 63.3k |
As of March 18, 2025, the stock is trading at USD 2.55 with a total of 42,041 shares traded.
Over the past week, the price has changed by +17.51%, over one month by -12.07%, over three months by -33.42% and over the past year by +5.81%.
No, based on ValueRay Analyses, Amesite Operating (NASDAQ:AMST) is currently (March 2025) a stock to sell. It has a ValueRay Growth Rating of -69.05 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMST as of March 2025 is 1.51. This means that AMST is currently overvalued and has a potential downside of -40.78%.
Amesite Operating has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy AMST.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, AMST Amesite Operating will be worth about 1.8 in March 2026. The stock is currently trading at 2.55. This means that the stock has a potential downside of -31.37%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7 | 174.5% |
Analysts Target Price | 7 | 174.5% |
ValueRay Target Price | 1.8 | -31.4% |